Lipoprotein subfractions highly associated with renal damage in familial lecithin: Cholesterol acyltransferase deficiency

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 8, 2014, Pages 1756-1762

  Kuroda, Masayuki ^a,b   Holleboom, Adriaan G ^c   Stroes, Erik S G ^c   Asada, Sakiyo ^a   Aoyagi, Yasuyuki ^a   Kamata, Kouju ^d   Yamashita, Shizuya ^e   Ishibashi, Shun ^f   Saito, Yasushi ^a   Bujo, Hideaki ^a,g  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d KITASATO UNIVERSITY HOSPITAL   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f JICHI MEDICAL UNIVERSITY   (Japan)

^g TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

Author keywords

Chromatography; Gel; LDL; lecithin acyltransferase deficiency; Renal insufficiency

Indexed keywords

CHROMATOGRAPHY, GEL; LDL; LECITHIN ACYLTRANSFERASE DEFICIENCY; RENAL INSUFFICIENCY;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME REPLACEMENT THERAPY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY; LECITHIN ACYLTRANSFERASE DEFICIENCY; LIPOPROTEINS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PROTEINURIA; RECOMBINANT PROTEINS; RENAL INSUFFICIENCY;

EID: 84904675333     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.303420     Document Type: Article

References (31)

1. Glomset JA, Assmann G, Gjone E, Norum KR. Lecithin cholesterol acyltransferase deficiency and fish eye disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Stanbury JB, Wyngaarden JB, Fredrickson DS, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th ed. New York, NY: McGraw-Hill Inc; 1995:1933-1951.
2. Santamarina-Fojo S, Hoeg JM, Assman G, Brewer HB Jr. Lecithin cholesterol acyltransferase deficiency and fish eye disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th ed. New York, NY: McGraw-Hill Inc;2001:2817-2833.
3. Human Gene Mutation Database. 2013. Human Gene Mutation Database. http://www.hgmd.org.
4. The Online Metabolic and Molecular Bases of Inherited Diseases (OMMBID), part 12: LIPIDS, http://www.ommbid.com/OMMBID/ theonlinemetabolicandmolecularbasesofinheriteddisease/b/abstract/part12/ch118.
5. Ségure t-Macé S, Latta-Mahieu M, Castro G, Luc G, Fruchart JC, Rubin E, Denèfle P, Duverger N. Potential gene therapy for lecithin-cholesterol acyltransferase (LCAT)-deficient and hypoalphalipoproteinemic patients w ith adenovirus-mediated transfer of human LCAT gene. Circulation. 1996;94:2177-2184.
6. Rousset X, Vaisman B, Auerbach B, Krause BR, Homan R, Stonik J, Csako G, Shamburek R, Remaley AT. Effect of recombinant human lecithin cholesterol acyltransferase infusion on lipoprotein metabolism in mice. J Pharmacol Exp Ther. 2010;335:140-148.
7. Kuroda M, Bujo H, Aso M, Saito Y. Adipocytes as a vehicle for ex vivo gene therapy: novel replacement therapy for diabetes and other metabolic diseases. J Diab etes Invest. 2011;2:333-340.
8. Chen Z, Chu D, Castro-Perez JM, et al. AAV8-mediated long-term expression of human LCAT significantly improves lipid profiles in hCETP;Ldlr(+/-) mice. J Cardiovasc Transl Res. 2011;4:801-810.
9. Kuroda M, Aoyagi Y, Asada S, Bujo H, Tanaka S, Konno S, Tanio M, Ishii I, Machida K, Matsumoto F, Satoh K, Aso M, Saito Y. Ceiling culturederived prol iferative adipocytes are a possible delivery vehicle for enzyme replacement therapy in lecithin: cholesterol acyltransferase deficiency. Open Gene Ther J. 2011;4:1-10.
10. Asada S, Kuroda M, Aoyagi Y, Bujo H, Tanaka S, Konno S, Tanio M, Ishii I, Aso M, Saito Y. Disturbed apolipoprotein A-I-containing lipoproteins in fish-eye disease are improved by the lecithin:cholesterol acyltransferase produced by gene-transduced adipocytes in vitro. Mol Genet Metab. 2011;102:229-231.
11. Glomset JA, Nichols AV, Norum KR, King W, Forte T. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency. Further studies of very l ow and low density lipoprotein abnormalities. J Clin Invest. 1973;52:1078-1092.
12. Forte T, Nichols A, Glomset J, Norum K. The ultrastructure of plasma lipoproteins in lecithin:cholesterol acyltransferase deficiency. Scand J Clin Lab Invest Suppl. 1974;137:121-132.
13. Glomset JA, Norum KR, King W. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: lipid composition and reactivity in vitro. J Clin Invest. 1970;49:1827-1837.
14. Norum KR, Glomset JA, Nichols AV, Forte T. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: physical and chemical studies of low and high density lipoproteins. J Clin Invest. 1971;50:1131-1140.
15. Guérin M, Dolphin PJ, Chapman MJ. Familial lecithin:cholesterol acyltransferase deficiency: further resolution of lipoprotein particle heterogeneity in the low density interval. Atherosclerosis. 1993;104:195-212.
16. Gjone E. Familial lecithin:cholesterol acyltransferase deficiency-a clinical survey. Scand J Clin Lab Invest Suppl. 1974;137:73-82.
17. Gjone E, Blomhoff JP, Skarbovik AJ. Possible association between an abnormal low density lipoprotein and nephropathy in lecithin: cholesterol acyltransferase deficiency. Clin Chim Acta. 1974;54:11-18.
18. Guerin M, Dachet C, Goulinet S, Chevet D, Dolphin PJ, Chapman MJ, Rouis M. Familial lecithin:cholesterol acyltransferase deficiency: molecular analysis of a compound heterozygote: LCAT (Arg147 -> Trp) and LCAT (Tyr171 -> Stop). Atherosclerosis. 1997;131:85-95.
19. Lambert G, Sakai N, Vaisman BL, et al. Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice. J Biol Chem. 2001;276:15090-15098.
20. Zhu X, Herzenberg AM, Eskandarian M, Maguire GF, Scholey JW, Connelly PW, Ng DS. A novel in vivo lecithin-cho lesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy. Am J Pathol. 2004;165:1269-1278.
21. Yee MS, Pavitt DV, Richmond W, Cook HT, McLean AG, Valabhji J, Elkeles RS. Changes in lipoprotein profile and urinary albumin excretion in familial LCAT deficiency with lipid lowering therapy. Atherosclerosis. 2009;205:528-532.
22. Lynn EG, Choy PC, Magil A, O K. Uptake and metabolism of lipoprotein- X in mesangial cells. Mol Cell Biochem. 1997;175:187-194.
23. Holleboom AG, Kuivenhoven JA, van Olden CC, Peter J, Schimmel AW, Levels JH, Valentijn RM, Vos P, Defesche JC, Kastelein JJ, Hovingh GK, Stroes ES, Hollak CE. Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferase. Atherosclerosis. 2011;216:161-165.
24. Naito S, Kamata M, Furuya M, Hayashi M, Kuroda M, Bujo H, Kamata K. Amelioration of circulating lipoprotein profile and proteinuria in a patient with LCAT d eficiency due to a novel mutation (Cys74Tyr) in the lid region of LCAT under a fat-restricted diet and ARB treatment. Atherosclerosis. 2013;228:193-197.
25. Wang XL, Osuga J, Tazoe F, Okada K, Nagashima S, Takahashi M, Ohshiro T, Bayasgalan T, Yagyu H, Okada K, Ishibashi S. Molecular analysis of a novel LCAT mutation (Gly179 → Arg) found in a patient with complete LCAT deficiency. J Atheroscler Thromb. 2011;18:713-719.
26. Asztalos BF, Schaefer EJ, Horvath KV, Yamashita S, Miller M, Franceschini G, Calabresi L. Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. J Lipid Res. 2007;48:592-599.
27. Holleboom AG, Kuivenhoven JA, Peelman F, Schimmel AW, Peter J, Defesche JC, Kastelein JJ, Hovingh GK, Stroes ES, Mo tazacker MM. High prevalence of mutations in LCAT in patients with low HDL cholesterol levels in The Netherlands: identification and characterization of eight novel mutations. Hum Mutat. 2011;32:1290-1298.
28. Hovingh GK, Hutten BA, Holleboom AG, Petersen W, Rol P., Stalenhoef A., Zwinderman AH, De Groot E., Kastelein JJ, Kuivenhoven JA. Compromised LCAT function is associated with increased atherosclerosis, Circulation. 2005,112. 879-884.
29. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
30. Glomset JA, Norum KR, Nichols AV, King WC, Mitchell CD, Applegate KR, Gong EL, Gjone E. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: e ffects of dietary manipulation. Scand J Clin Lab Invest Suppl. 1975;142:3-30.
31. Nishiwaki M, Ikewaki K, Bader G, Nazih H, Hannuksela M, Remaley AT, Shamburek RD, Brewer HB Jr. Human lecithin:cholesterol acyltransferase deficiency: in vivo kinetics of low-density lipoprotein and lipoprotein-X. Arterioscler Thromb Vasc Biol. 2006;26:1370-1375.